Scarica l'app Stockscreener
10.89
4.85%
-0.555
Dopo l'orario di chiusura:
11.11
0.215
+1.97%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$11.45
Aprire:
$11.58
Volume 24 ore:
831.19K
Relative Volume:
1.33
Capitalizzazione di mercato:
$332.34M
Reddito:
$40.61M
Utile/perdita netta:
$-29.07M
Rapporto P/E:
-10.81
EPS:
-1.0081
Flusso di cassa netto:
$-26.70M
1 W Prestazione:
-26.53%
1M Prestazione:
-23.86%
6M Prestazione:
+16.28%
1 anno Prestazione:
-56.51%
Intervallo 1D:
$10.85
$11.58
Intervallo di 1 settimana:
$10.85
$15.42
Portata 52W:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Nome
Clearpoint Neuro Inc
Settore
Industria
Telefono
(949) 900-6833
Indirizzo
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
10.89 | 452.38M | 40.61M | -29.07M | -26.70M | -1.0081 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2023-10-24 | Iniziato | Stifel | Buy |
| 2023-02-16 | Ripresa | B. Riley Securities | Buy |
| 2022-04-05 | Ripresa | B. Riley Securities | Buy |
| 2021-03-18 | Iniziato | Lake Street | Buy |
| 2020-07-17 | Iniziato | B. Riley FBR | Buy |
Mostra tutto
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
ClearPoint Neuro: My Speculative Buy Didn't Pan Out, Moving To Hold (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro Inc (CLPT) Stock Up 3.7% and Still Undervalued -- GF Score: 75/100 - GuruFocus
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Axsome Therapeutics (AXSM) - The Globe and Mail
A Look at ClearPoint Neuro Inc (CLPT) After 23.1% Decline -- GF Value $14.76 vs Price $11.77 - GuruFocus
ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update - Yahoo Finance
ClearPoint Neuro stock tumbles on uniQure trial setback By Investing.com - Investing.com Canada
The Technical Signals Behind (CLPT) That Institutions Follow - Stock Traders Daily
ClearPoint Neuro Inc (CLPT) Stock Price Today: $14.86 - Pluang
ClearPoint Neuro stock gains on recent momentum despite limited data - AD HOC NEWS
Stifel reiterates Clearpoint Neuro stock rating citing CGT focus - Investing.com
Stifel reiterates Clearpoint Neuro stock rating citing CGT focus By Investing.com - Investing.com Canada
Understanding the Setup: (CLPT) and Scalable Risk - Stock Traders Daily
ClearPoint Neuro stock slips as revenue misses estimates - AD HOC NEWS
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment - Yahoo Finance
ClearPoint Neuro Company Profile & Introduction - Moomoo
How (CLPT) Movements Inform Risk Allocation Models - Stock Traders Daily
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $25 - Moomoo
ClearPoint Neuro (CLPT) Retreats Nearly 4% as Shares Test Key Technical SupportHigh Beta Stocks - careplusvn.com
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - ACCESS Newswire
ClearPoint Neuro (CLPT) Q2 2026 Earnings: EPS Misses Estimates by Nearly 30%Weak Earnings Momentum - dars.gov.et
ClearPoint Neuro stock holds recent gains as earnings and analyst targets frame the next move - AD HOC NEWS
ClearPoint (CLPT) Quarter in Focus: The Bottom-Line Figure Trails Its Comparison at the Close; Price Reaction: Shares Finish 11.80% Up on the DayEarnings Growth Analysis - dars.gov.et
ClearPoint (CLPT) Results at a Glance: The Bottom-Line Figure Trails Its Comparison in the Current Update; Trading Response: Shares Fall 2.01% at the CloseBuyback Announcement Report - vinanet.vn
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
Conway Capital Management Inc. Makes New $1.66 Million Investment in ClearPoint Neuro, Inc. $CLPT - MarketBeat
ClearPoint Neuro (CLPT) Edges Lower as Shares Consolidate Between $14.57 Support and $16.11 ResistanceBullish Sentiment - vinanet.vn
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript - AOL.com
(CLPT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ClearPoint Neuro (CLPT): MAK Capital group discloses 7.8% ownership in 13G/A - Stock Titan
ClearPoint Neuro (CLPT) Jumps 6.12% to $14.21: Key Levels to WatchPCR Spike - dars.gov.et
ClearPoint Neuro (NASDAQ:CLPT) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts Have Lowered Expectations For ClearPoint Neuro, Inc. (NASDAQ:CLPT) After Its Latest Results - 富途牛牛
Clearpoint Neuro Inc (CLPT) Stock News Today - TradingKey
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
ClearPoint Neuro, Inc. (CLPT) Options Chain - Yahoo! Finance Canada
CLPT Looks 4.6% Overvalued on GF Value™ Ahead of Tuesday Market Drop - GuruFocus
ClearPoint Neuro: Regulatory Momentum Strengthens The Long-Term Investment Case (CLPT) - Seeking Alpha
ClearPoint Neuro Updates Q2 Results and 2026 Outlook - The Globe and Mail
ClearPoint Neuro (CLPT) investors disclose 7.45% beneficial ownership stake - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Cuts Target Price to $25 - Moomoo
Stifel cuts Clearpoint Neuro stock price target on guidance cut - Investing.com
Stifel cuts Clearpoint Neuro stock price target on guidance cut By Investing.com - Investing.com South Africa
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks - Benzinga
CLPT Looks 4.7% Overvalued on GF Value™ - GuruFocus
How Does ClearPoint Neuro Inc (CLPT) Perform in Q2? EPS at -$0.3 - GuruFocus
Earnings call transcript: Clearpoint Neuro Q2 2026 misses estimates as shares fall - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
ClearPoint Neuro Q2 Earnings Call Highlights - Yahoo Finance
Clearpoint Neuro Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Clearpoint Neuro Inc Azioni (CLPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Clearpoint Neuro Inc Azioni (CLPT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH | CEO and President |
Jun 29 '26 |
Option Exercise |
2.50 |
20,000 |
50,000 |
136,842 |
| BURNETT JOSEPH | CEO and President |
Jun 29 '26 |
Sale |
19.38 |
20,000 |
387,600 |
116,842 |
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):